@@ -282,7 +282,7 @@ Tianjin Medical University Cancer Institute & Hospital is the birthplace of onco
The hospital covers area of 63,000 square meters and 175,052square meters of the building area. In 2017, there were 1,150,000 outpatient clinic visits, 86,000 In-patients visits and 30,000 operations. TMUCIH has 3000 full-time staff members; among them are 275 senior professionals including an academician from The Chinese Academy of Engineering, a Specially Appointed Professor and two Visiting Professors from the National Yangtze Scholar Plan, 15 experts who enjoy The Special Allowance from the State Council and 6 experts ranked as Excellent Talents of the New Century by the Ministry of Education.
</p>
<p>
The most recognized specialties in the hospital are basic and clinical research on breast cancer, lung cancer, biotherapy, molecular imaging, radiation oncology, medical oncology, pathology as well as cancer Epidemiology. Oncology is a National Key subject and a“National 211 Project” Key Construction Subject. The hospital has a Key Breast Cancer Prevention and Treatment Laboratory authorized by the Ministry of Education and two Ministry of Education Innovation Teams, a National Experimental Clinical Medicine Institute, and a Ministry of Health National Continuing Medical Education Base, . Oncology, chest surgery, pathology and nursing are selected national key clinical construction specialties. The hospital Breast Cancer Center is the largest one in China.
The most recognized specialties in the hospital are basic and clinical research on breast cancer, lung cancer, biotherapy, molecular imaging, <!-- -->, medical oncology, pathology as well as cancer Epidemiology. Oncology is a National Key subject and a“National 211 Project” Key Construction Subject. The hospital has a Key Breast Cancer Prevention and Treatment Laboratory authorized by the Ministry of Education and two Ministry of Education Innovation Teams, a National Experimental Clinical Medicine Institute, and a Ministry of Health National Continuing Medical Education Base, . Oncology, chest surgery, pathology and nursing are selected national key clinical construction specialties. The hospital Breast Cancer Center is the largest one in China.
The Department of Radiation Oncology at Tianjin Medical University Cancer Institute and Hospital is one of the largest departments of radiation oncology in China It serves as one of the national training bases for radiation oncologist, a training base
for Swedish Elekta Company, and the education and training center for master candidates from Tianjin Medical University. Our department combines clinical expertise, compassionate care, and advanced radiation therapies to deliver
the safest, most effective treatments for cancer and benign tumors. We strive to excite, educate, encourage, train and mentor a diverse team of physicians, physicists, radiation therapists, and dosimetrists to become excellent
caregivers, to develop methods to improve outcomes for their community, and to become future leaders in academic medicine and/or healthcare delivery.
The Department of
<!-- -->at Tianjin Medical University Cancer Institute and Hospital is one of the largest departments of
<!-- -->in China It serves as one of the national training bases for radiation oncologist, a training base for Swedish Elekta Company, and the education and training center for master candidates from Tianjin Medical University. Our
department combines clinical expertise, compassionate care, and advanced radiation therapies to deliver the safest, most effective treatments for cancer and benign tumors. We strive to excite, educate, encourage, train and
mentor a diverse team of physicians, physicists, radiation therapists, and dosimetrists to become excellent caregivers, to develop methods to improve outcomes for their community, and to become future leaders in academic medicine
and/or healthcare delivery.
</div><br/><br/>
<divclass="contant_words">
The department have international first-class radiation therapy equipments: 5 medical linear accelerators, 1 full-digital simulator, 1 spiral CT simulator, 19 sets of inverse 3-dimensional planning system, 1 brachytherapy equipment, and 3 microwave machines
...
...
@@ -420,9 +428,10 @@
2. Faculty and staff
</div>
<divclass="contant_words">
The department of radiation oncology is the largest department in our hospital, which including four wards, radiation physics and maintenance sub-groups. All the radiation oncologists pay special attention to the improvement of radiation technique and
the multiple modality therapy. The radiation physics and maintenance groups are in charge of the daily quality assurance and quality control. The well cooperation between each groups assure the improvement of clinical treatment
and the development of advanced techniques.
The department of
<!-- -->is the largest department in our hospital, which including four wards, radiation physics and maintenance sub-groups. All the radiation oncologists pay special attention to the improvement of radiation technique and the multiple
modality therapy. The radiation physics and maintenance groups are in charge of the daily quality assurance and quality control. The well cooperation between each groups assure the improvement of clinical treatment and the
development of advanced techniques.
</div>
<divclass="contant_words">
As the largest department of Tianjin Medical University Cancer Institute and Hospital, we have a high level professional team, which consists of 45 radiation oncologists, 8 physicists, 8 dosimetrists, 38 radiation therapists, 5 engineers, and 78 nurses.
...
...
@@ -457,7 +466,8 @@
outcomes. These clinical practices indicate that the radiotherapy technique in our department reaches the top-rank in our country.
</div>
<divclass="contant_words">
The mission of Department of Radiation Oncology at Tianjin Medical University Cancer Institute and Hospital is to provide excellence in patient care by administering the highest level of quality in a safe and compassionate environment.
The mission of Department of
<!-- -->at Tianjin Medical University Cancer Institute and Hospital is to provide excellence in patient care by administering the highest level of quality in a safe and compassionate environment.
</div>
</div>
</div>
...
...
@@ -467,80 +477,15 @@
<div class="top_img_box">
</div>
<div class="depart_introduce">
<h4>Department of Radiation Oncology</h4>
<h4>Department of <!-- -->
</h4>
<p>
General introduction
The Department of Radiation Oncology at Tianjin Medical University Cancer Institute and
Hospital is one of the largest departments of radiation oncology in China It serves as one
of the national training bases for radiation oncologist, a training base for Swedish Elekta
Company, and the education and training center for master candidates from Tianjin Medical
University. Our department combines clinical expertise, compassionate care, and advanced
radiation therapies to deliver the safest, most effective treatments for cancer and benign
tumors. We strive to excite, educate, encourage, train and mentor a diverse team of
physicians, physicists, radiation therapists, and dosimetrists to become excellent
caregivers, to develop methods to improve outcomes for their community, and to become future
leaders in academic medicine and/or healthcare delivery.<br>
The department have international first-class radiation therapy equipments: 5 medical linear
Prof. Wang received his medical degree from Tianjin Medical University in 1983 and has been Radiation Oncologist for about 24 years. He received advance studies in the Department of Radiation Oncology in University Basel in Switzerland and Frankfurt University
Prof. Wang received his medical degree from Tianjin Medical University in 1983 and has been Radiation Oncologist for about 24 years. He received advance studies in the Department of <!-- --> in University Basel in Switzerland and Frankfurt University
in Germany respectively during 1989 and 1995. <br/>Prof. Wang is one of the famous radiation oncologists in China. He is proficient in various radiation techniques, such as 3-dimensional conformal radiation therapy,
intensity modulated radiation therapy, interstitial brachytherapy, stereotactic radiosurgery etc. He is accomplished in interstitial brachytherapy in soft tissue sarcoma, in cancer of the tongue. He is experienced in many kinds of
malignant tumors, including lung cancer, esophageal carcinoma, nasopharyngeal carcinoma, laryngeal carcinoma, breast cancer, rectal cancer, etc. Now, his clinical and research field are mainly focused on thoracic malignancies.<br/>Prof.
Wang has served as the standing director of the Chinese Anti-Cancer Association and the Vice Chairman of the Radiation Oncology. He participated and accomplished the National Program “Promoting of the Radiological therapeutic effect
Wang has served as the standing director of the Chinese Anti-Cancer Association and the Vice Chairman of the <!-- -->. He participated and accomplished the National Program “Promoting of the Radiological therapeutic effect
for Cancer”. He also took part in 2 projects of Natural Science Foundation of China and 4 Public Health Bureau Issues. He has introduced 4 new techniques including High-dose-rate of Interstitial Brachytherapy for Oral Malignant Tumor
into the hospital.
<br/>He has published 20 articles on national publication and international conference in which 4 papers were included in SCI journals. Furthermore
...
...
@@ -450,7 +450,7 @@
<p style="font-size: 18px">
Prof. Wang received his medical degree from Tianjin Medical University in 1983 and has
been Radiation Oncologist for about 24 years. He received advance studies in the
Department of Radiation Oncology in University Basel in Switzerland and Frankfurt
Department of <!-- --> in University Basel in Switzerland and Frankfurt
University in Germany respectively during 1989 and 1995.
Prof. Wang is one of the famous radiation oncologists in China. He is proficient in
various radiation techniques, such as 3-dimensional conformal radiation therapy,
...
...
@@ -461,7 +461,7 @@
carcinoma, breast cancer, rectal cancer, etc. Now, his clinical and research field are
mainly focused on thoracic malignancies.
Prof. Wang has served as the standing director of the Chinese Anti-Cancer Association
and the Vice Chairman of the Radiation Oncology. He participated and accomplished the
and the Vice Chairman of the <!-- -->. He participated and accomplished the
National Program “Promoting of the Radiological therapeutic effect for Cancer”. He also
took part in 2 projects of Natural Science Foundation of China and 4 Public Health
Bureau Issues. He has introduced 4 new techniques including High-dose-rate of
The Clinical Trial Research Center of Tianjin Medical University Cancer Institute & Hospital was founded in 1996 and was approved by the Ministry of Health in 1998, respectively. It is one of the earliest clinical trial research center established in
China. In May 2015, it passed the re-inspection of CFDA.
</div>
<divclass="contant_right_words">
The concept of the Center is "scientific management, standardized operation, and true evaluation". The Center has been developing rapidly based upon the 11th Five-Year Plan to 13th Five-Year Plan. Anti-cancer drug clinical trials conducted in our hospital
have been increasing year by year and the quality of clinical trials has been highly appreciated. So far, the Center has undertaken more than 500 clinical trials from Phase I to Phase IV, including nearly 300 State Category
I New Drug. Approximately 15 000 cases were completed and more than 50 new anticancer drugs have been approved.
</div>
<divclass="contant_right_words">
The Center is one of the earliest clinical trial research centers in China to adopt clinical trial information Management system (CTIMS) and centralized management of experimental drugs, and is now leading the country in these aspects. The experiences
have been forward to other centers, including Cancer Hospital Chinese Academy of Medical Sciences, Beijing Cancer Hospital, Hunan Cancer Hospital, Jiangxi Cancer Hospital, and Shandong Cancer Hospital. In 2015, the centralization
pharmacy was under on-site inspection and was rated as excellent by the “Clinical Investigational Drug Centralized Management Project” initiated by the GCP Alliance of China. The center participated in the establishment of
the Tianjin Clinical Research Technology Service Innovation Center, and established a joint laboratory for the analysis and testing of new drug clinical research samples, and developed the front-end technology development of
AI-assisted clinical trials based on big data to empower clinical trials with quantity, quality and efficiency.
</div>
<divclass="content-word-right active">
<divclass="contant_right_words">
Through hard work, the Center has become the governing unit of China GCP Alliance, China Cancer Clinical Trial Auditing Collaboration Group, China Tumor Phase I (BE/Consistency Evaluation) Collaborative Group, China Anti-Cancer Association Cancer Drug
Clinical Research Committee, China Anti-Cancer Association Medical Ethics Committee Tianjin Hospital Association, Clinical Trial Special Committee and Clinical Research Coordinator (CRC) platform of the main unit. Based upon
the accumulated academic status and rich experience over the years, the Center has played a leading role in Tianjin and even in China, which promotes the development of cancer clinical trials in China.
